Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remco van Doorn

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
The Journal of Investigative Dermatology|August 1, 2025
Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical OutcomeKarin van den Hurk, Kim Lommen, Louis Coussement, et al.
JCO Precision Oncology|November 21, 2022
Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in <i>CDKN2A</i> and Pancreatic CancerEsteban Astiazaran-Symonds, Cole Graham, Jung Kim, et al.
Pigment Cell & Melanoma Research|February 14, 2012
Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL studyJohn R Davies, Juliette Randerson-Moor, Kairen Kukalizch, et al.
Cancers|August 7, 2019
Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening GuidelinesCindy Chau, Remco van Doorn, Natasha M van Poppelen, et al.
Human Genetics|July 25, 2016
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutationsXiaohong R Yang, Melissa Rotunno, Yanzi Xiao, et al.
Cancers|November 26, 2022
Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma: A Nation-Wide Study of the Dutch Melanoma Treatment RegistryDaan Jan Willem Rauwerdink, Remco van Doorn, Jos van der Hage, et al.
Cancers|August 10, 2024
Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma PatientsDaan Jan Willem Rauwerdink, Olivier van Not, Melissa de Meza, et al.
Pigment Cell & Melanoma Research|November 14, 2013
An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL studyJohn R Davies, Sinead Field, Juliette Randerson-Moor, et al.
International Journal of Cancer|February 19, 2014
Inherited variation in the PARP1 gene and survival from melanomaJohn R Davies, Rosalyn Jewell, Paul Affleck, et al.
Journal of Medical Genetics|June 9, 2017
Germline <i>CDKN2A</i>/P16INK4A mutations contribute to genetic determinism of sarcomaFanélie Jouenne, Isaure Chauvot de Beauchene, Emeline Bollaert, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
The Journal of Investigative Dermatology|August 1, 2025
Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical OutcomeKarin van den Hurk, Kim Lommen, Louis Coussement, et al.
JCO Precision Oncology|November 21, 2022
Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in <i>CDKN2A</i> and Pancreatic CancerEsteban Astiazaran-Symonds, Cole Graham, Jung Kim, et al.
Pigment Cell & Melanoma Research|February 14, 2012
Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL studyJohn R Davies, Juliette Randerson-Moor, Kairen Kukalizch, et al.
Cancers|August 7, 2019
Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening GuidelinesCindy Chau, Remco van Doorn, Natasha M van Poppelen, et al.
Human Genetics|July 25, 2016
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutationsXiaohong R Yang, Melissa Rotunno, Yanzi Xiao, et al.
Cancers|November 26, 2022
Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma: A Nation-Wide Study of the Dutch Melanoma Treatment RegistryDaan Jan Willem Rauwerdink, Remco van Doorn, Jos van der Hage, et al.
Cancers|August 10, 2024
Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma PatientsDaan Jan Willem Rauwerdink, Olivier van Not, Melissa de Meza, et al.
Pigment Cell & Melanoma Research|November 14, 2013
An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL studyJohn R Davies, Sinead Field, Juliette Randerson-Moor, et al.
International Journal of Cancer|February 19, 2014
Inherited variation in the PARP1 gene and survival from melanomaJohn R Davies, Rosalyn Jewell, Paul Affleck, et al.
Journal of Medical Genetics|June 9, 2017
Germline <i>CDKN2A</i>/P16INK4A mutations contribute to genetic determinism of sarcomaFanélie Jouenne, Isaure Chauvot de Beauchene, Emeline Bollaert, et al.
Pageof 12